OIG Increases Expectations for Compliance Officers in Its New Compliance Program Guidance – What Compliance Officers at Pharmaceutical and Medical Device Companies Need to Consider | King & Spalding
On November 6, 2023, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) issued its anticipated General Compliance Program Guidance (“GCPG”) for the...
United States Cpgs Icpgs Compliance Program Guidance Disclosure Program Compliance Program Guidance For Pharmaceutical Manufacturers Effective Lines Of Communications
Source: jdsupra.com